BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30390660)

  • 1. Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification.
    Davis J; Desmond M; Berk M
    BMC Nephrol; 2018 Nov; 19(1):305. PubMed ID: 30390660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal.
    Davis J; Desmond M; Berk M
    Nephrology (Carlton); 2018 Oct; 23(10):897-903. PubMed ID: 29607573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic renal complications induced by lithium].
    Le Roy V; Delmas Y; Verdoux H
    Encephale; 2009 Dec; 35(6):605-10. PubMed ID: 20004292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder.
    Hayes JF; Osborn DPJ; Francis E; Ambler G; Tomlinson LA; Boman M; Wong ICK; Geddes JR; Dalman C; Lewis G
    BMC Med; 2021 Apr; 19(1):99. PubMed ID: 33906644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium nephrotoxicity.
    Oliveira JL; Silva Júnior GB; Abreu KL; Rocha Nde A; Franco LF; Araújo SM; Daher Ede F
    Rev Assoc Med Bras (1992); 2010; 56(5):600-6. PubMed ID: 21152836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent nephrogenic diabetes insipidus following lithium therapy.
    Thompson CJ; France AJ; Baylis PH
    Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal complications of lithium use: to cease or to continue?].
    Beunders AJM; Hillegers MHJ; Regeer EJ; Vervloet MG; Gaillard CAJM; Dols A
    Ned Tijdschr Geneeskd; 2018 May; 162():. PubMed ID: 30040291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium-induced nephropathies.
    Raedler TJ; Wiedemann K
    Psychopharmacol Bull; 2007; 40(2):134-49. PubMed ID: 17514192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study.
    Kessing LV; Gerds TA; Feldt-Rasmussen B; Andersen PK; Licht RW
    JAMA Psychiatry; 2015 Dec; 72(12):1182-91. PubMed ID: 26535805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium in the Kidney: Friend and Foe?
    Alsady M; Baumgarten R; Deen PM; de Groot T
    J Am Soc Nephrol; 2016 Jun; 27(6):1587-95. PubMed ID: 26577775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrotoxicity and long-term treatment with lithium].
    Gahr M; Freudenmann RW; Connemann BJ; Keller F; Schönfeldt-Lecuona C
    Psychiatr Prax; 2014 Jan; 41(1):15-22. PubMed ID: 24089323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent nephrogenic diabetes insipidus, tubular proteinuria, aminoaciduria, and parathyroid hormone resistance following longterm lithium administration.
    Neithercut WD; Spooner RJ; Hendry A; Dagg JH
    Postgrad Med J; 1990 Jun; 66(776):479-82. PubMed ID: 2170960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.
    Damba JJ; Bodenstein K; Lavin P; Drury J; Sekhon H; Renoux C; Trinh E; Rej S; Greenway KT
    CNS Drugs; 2022 Oct; 36(10):1049-1077. PubMed ID: 36161425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort study.
    Pahwa M; Joseph B; Nunez NA; Jenkins GD; Colby CL; Kashani KB; Marin Veldic ; Moore KM; Betcher HK; Ozerdem A; Cuellar-Barboza AB; McElroy SL; Biernacka JM; Frye MA; Singh B
    Bipolar Disord; 2021 Nov; 23(7):715-723. PubMed ID: 33548063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of renal disease in older lithium users: a population-based study.
    Rej S; Shulman K; Herrmann N; Harel Z; Fischer HD; Fung K; Gruneir A
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1075-82. PubMed ID: 24566239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders.
    Rej S; Elie D; Mucsi I; Looper KJ; Segal M
    Drugs Aging; 2015 Jan; 32(1):31-42. PubMed ID: 25519823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal concerns relative to the use of lithium in geriatric bipolar disorder patients.
    Szpunar J; Maeshima H; Grossberg GT
    Ann Clin Psychiatry; 2017 Nov; 29(4):283-290. PubMed ID: 29069113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of long-term lithium treatment on kidney function].
    Rybakowski J; Drogowska J; Abramowicz M; Chłopocka-Woźniak M; Czekalski S
    Psychiatr Pol; 2012; 46(4):627-36. PubMed ID: 23214164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trade-off between the benefits of lithium treatment and the risk of chronic kidney disease.
    Adam WR; Schweitzer I; Walker RG
    Nephrology (Carlton); 2012 Nov; 17(8):776-9. PubMed ID: 23107125
    [No Abstract]   [Full Text] [Related]  

  • 20. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
    Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
    BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.